Drug Approval | October 06, 2021
Lupin receives tentative approval for Brexpiprazole tablets
This product will be manufactured at Lupin’s Pithampur facility In India
This product will be manufactured at Lupin’s Pithampur facility In India
According to IQVIA, US sales of Everolimus (Afinitor) tablets were approximately US $ 675 million in the 12 months ending July 2021
One batch has 11.4 million units of Naproxen tablets out of which 0.9 million units that were released into the market were recalled
The drug will be manufactured at the group's formulation manufacturing facility at the SEZ, Ahmedabad.
Zydus’ Sitagliptin base contains the active moiety Sitagliptin in a different form than used in the branded reference product, Januvia (Sitagliptin Phosphate)
The company will manufacture the products at its US FDA approved oral dosage facility at Goa in India
Brivaracetam tablets are indicated for the treatment of partial-onset seizures in patients four years of age and older
Ibuprofen and Famotidine Tablets is an AB-rated generic therapeutic equivalent version of Horizon Medicines LLC’s Duexis Tablets, 800 mg/26.6 mg
It is part of the company’s pain/analgesics portfolio of OTC products
The company has already embarked upon significant expansion in Turkey
Subscribe To Our Newsletter & Stay Updated
